Analystreport

Coherus BioSciences (NASDAQ: CHRS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com